logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Locally advanced pancreatic cancer: nab-paclitaxel+gemcitabine shows promise

No prospective data are available for this regimen or FOLFIRINOX in this population.